175 related articles for article (PubMed ID: 17675213)
21. 3D-QSAR studies of heterocyclic quinones with inhibitory activity on vascular smooth muscle cell proliferation using pharmacophore-based alignment.
Ryu CK; Lee Y; Park SG; You HJ; Lee RY; Lee SY; Choi S
Bioorg Med Chem; 2008 Nov; 16(22):9772-9. PubMed ID: 18930405
[TBL] [Abstract][Full Text] [Related]
22. CoMFA and HQSAR studies on 6,7-dimethoxy-4-pyrrolidylquinazoline derivatives as phosphodiesterase10A inhibitors.
Kulkarni SS; Patel MR; Talele TT
Bioorg Med Chem; 2008 Apr; 16(7):3675-86. PubMed ID: 18299198
[TBL] [Abstract][Full Text] [Related]
23. Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.
Rivara S; Mor M; Silva C; Zuliani V; Vacondio F; Spadoni G; Bedini A; Tarzia G; Lucini V; Pannacci M; Fraschini F; Plazzi PV
J Med Chem; 2003 Apr; 46(8):1429-39. PubMed ID: 12672242
[TBL] [Abstract][Full Text] [Related]
24. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
Vaidya M; Weigt M; Wiese M
Eur J Med Chem; 2009 Oct; 44(10):4070-82. PubMed ID: 19515462
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic insights into the selectivity of bicyclophosphorothionate antagonists for housefly versus rat GABA receptors.
Zheng X; Liu G; Ozoe Y; Ju XL
Pest Manag Sci; 2024 Mar; 80(3):1382-1399. PubMed ID: 37926485
[TBL] [Abstract][Full Text] [Related]
26. Meta-diamide insecticides acting on distinct sites of RDL GABA receptor from those for conventional noncompetitive antagonists.
Nakao T; Banba S; Nomura M; Hirase K
Insect Biochem Mol Biol; 2013 Apr; 43(4):366-75. PubMed ID: 23416568
[TBL] [Abstract][Full Text] [Related]
27. Chloride channels of glycine and GABA receptors with blockers: Monte Carlo minimization and structure-activity relationships.
Zhorov BS; Bregestovski PD
Biophys J; 2000 Apr; 78(4):1786-803. PubMed ID: 10733960
[TBL] [Abstract][Full Text] [Related]
28. Improving the quality of 3D-QSAR by using flexible-ligand receptor models.
Pei J; Chen H; Liu Z; Han X; Wang Q; Shen B; Zhou J; Lai L
J Chem Inf Model; 2005; 45(6):1920-33. PubMed ID: 16309299
[TBL] [Abstract][Full Text] [Related]
29. Comparative molecular field analysis of quinoline derivatives as selective and noncompetitive mGluR1 antagonists.
Sekhar YN; Nayana MR; Ravikumar M; Mahmood SK
Chem Biol Drug Des; 2007 Dec; 70(6):511-9. PubMed ID: 18005334
[TBL] [Abstract][Full Text] [Related]
30. Medicinal chemistry of ρ GABAC receptors.
Ng CK; Kim HL; Gavande N; Yamamoto I; Kumar RJ; Mewett KN; Johnston GA; Hanrahan JR; Chebib M
Future Med Chem; 2011 Feb; 3(2):197-209. PubMed ID: 21428815
[TBL] [Abstract][Full Text] [Related]
31. Structural model for gamma-aminobutyric acid receptor noncompetitive antagonist binding: widely diverse structures fit the same site.
Chen L; Durkin KA; Casida JE
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):5185-90. PubMed ID: 16537435
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for androgen receptor agonists and antagonists: interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR.
Tamura H; Ishimoto Y; Fujikawa T; Aoyama H; Yoshikawa H; Akamatsu M
Bioorg Med Chem; 2006 Nov; 14(21):7160-74. PubMed ID: 16876421
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional QSAR analyses of 1,3,4-trisubstituted pyrrolidine-based CCR5 receptor inhibitors.
Zhuo Y; Kong R; Cong XJ; Chen WZ; Wang CX
Eur J Med Chem; 2008 Dec; 43(12):2724-34. PubMed ID: 18538451
[TBL] [Abstract][Full Text] [Related]
34. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies.
Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK
J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164
[TBL] [Abstract][Full Text] [Related]
35. GABA receptor antagonists and insecticides: common structural features of 4-alkyl-1-phenylpyrazoles and 4-alkyl-1-phenyltrioxabicyclooctanes.
Sammelson RE; Caboni P; Durkin KA; Casida JE
Bioorg Med Chem; 2004 Jun; 12(12):3345-55. PubMed ID: 15158803
[TBL] [Abstract][Full Text] [Related]
36. 3D QSAR studies of 1,3,4-benzotriazepine derivatives as CCK2 receptor antagonists.
Kaur K; Talele TT
J Mol Graph Model; 2008 Nov; 27(4):409-20. PubMed ID: 18774323
[TBL] [Abstract][Full Text] [Related]
37. Novel gamma-aminobutyric acid rho1 receptor antagonists; synthesis, pharmacological activity and structure-activity relationships.
Kumar RJ; Chebib M; Hibbs DE; Kim HL; Johnston GA; Salam NK; Hanrahan JR
J Med Chem; 2008 Jul; 51(13):3825-40. PubMed ID: 18528996
[TBL] [Abstract][Full Text] [Related]
38. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
Liang H; Wu X; Yalowich JC; Hasinoff BB
Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852
[TBL] [Abstract][Full Text] [Related]
39. A molecular basis for agonist and antagonist actions at GABA(C) receptors.
Abdel-Halim H; Hanrahan JR; Hibbs DE; Johnston GA; Chebib M
Chem Biol Drug Des; 2008 Apr; 71(4):306-27. PubMed ID: 18312293
[TBL] [Abstract][Full Text] [Related]
40. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis.
Roy KK; Dixit A; Saxena AK
J Mol Graph Model; 2008 Sep; 27(2):197-208. PubMed ID: 18515163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]